Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l -DOPA treatment and changes in levodopa-induced dyskinesia

Expanding the repertoire of L-DOPA’s actions: A comprehensive review of its functional neurochemistry

(2017) Philippe De Deurwaerdère et al.   PROGRESS IN NEUROBIOLOGY

MDS clinical diagnostic criteria for Parkinson's disease

(2015) Ronald B. Postuma et al.   MOVEMENT DISORDERS

Increased CSF biomarkers of angiogenesis in Parkinson disease

(2015) Shorena Janelidze et al.   NEUROLOGY

Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease

(2015) Matthieu F. Bastide et al.   PROGRESS IN NEUROBIOLOGY

Effects of noradrenergic denervation by anti-DBH-saporin on behavioral responsivity to l-DOPA in the hemi-parkinsonian rat

(2014) Corinne Y. Ostock et al.   BEHAVIOURAL BRAIN RESEARCH

Complexity of dopamine metabolism

(2013) Johannes Meiser et al.   Cell Communication and Signaling

Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease

(2013) C. Warren Olanow et al.   MOVEMENT DISORDERS

Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia

(2013) Erwan Bezard et al.   MOVEMENT DISORDERS

Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson’s disease and other synucleinopathies

(2012) David S. Goldstein et al.   BRAIN

l-DOPA pharmacokinetics in the MPTP-lesioned macaque model of Parkinson's disease

(2012) Philippe Huot et al.   NEUROPHARMACOLOGY

Genetic KCa3.1-Deficiency Produces Locomotor Hyperactivity and Alterations in Cerebral Monoamine Levels

(2012) Kate Lykke Lambertsen et al.   PLoS One

Vascular endothelial growth factor is upregulated by l-dopa in the parkinsonian brain: implications for the development of dyskinesia

(2011) K. Elisabet Ohlin et al.   BRAIN

CSF xanthine, homovanillic acid, and their ratio as biomarkers of Parkinson's disease

(2011) Peter LeWitt et al.   BRAIN RESEARCH

Pramipexole is active in depression tests and modulates monoaminergic transmission, but not brain levels of BDNF in mice

(2011) Olaf Schulte-Herbrüggen et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Contribution of pre-synaptic mechanisms to l-DOPA-induced dyskinesia

(2011) M. Carta et al.   NEUROSCIENCE

Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by α- and β-adrenergic receptor antagonists in hemiparkinsonian rats

(2011) Christopher J. Barnum et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

The locus coeruleus Is Directly Implicated in L-DOPA-Induced Dyskinesia in Parkinsonian Rats: An Electrophysiological and Behavioural Study

(2011) Cristina Miguelez et al.   PLoS One

Striatal Signaling in L-DOPA-Induced Dyskinesia: Common Mechanisms with Drug Abuse and Long Term Memory Involving D1 Dopamine Receptor Stimulation

(2011) Mario Gustavo Murer et al.   Frontiers in Neuroanatomy

DOES O-METHYL-DOPA PLAY A ROLE IN LEVODOPA-INDUCED DYSKINESIAS?

(2010) Cl. Feuerstein et al.   ACTA NEUROLOGICA SCANDINAVICA

CSF and plasma concentrations of free norepinephrine, dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), 3,4-dihydroxyphenylalanine (DOPA), and epinephrine in Parkinson's disease.

(2010) E. Eldrup et al.   ACTA NEUROLOGICA SCANDINAVICA

Cerebrospinal fluid metabolite and nigrostriatal dopaminergic function in Parkinson’s disease

(2009) K. Ishibashi et al.   ACTA NEUROLOGICA SCANDINAVICA

Dopamine transporter relation to levodopa-derived synaptic dopamine in a rat model of Parkinson’s: anin vivoimaging study

(2009) Vesna Sossi et al.   JOURNAL OF NEUROCHEMISTRY

Relationship of Striatal Dopamine Synthesis Capacity to Age and Cognition

(2008) M. N. Braskie et al.   JOURNAL OF NEUROSCIENCE

The Unified Dyskinesia Rating Scale: Presentation and clinimetric profile

(2008) Christopher G. Goetz et al.   MOVEMENT DISORDERS

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

(2008) Christopher G. Goetz et al.   MOVEMENT DISORDERS

Age-dependent decline of steady state dopamine storage capacity of human brain: An FDOPA PET study

(2008) Yoshitaka Kumakura et al.   NEUROBIOLOGY OF AGING

Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy

(2008) David S. Goldstein et al.   PARKINSONISM & RELATED DISORDERS

Correlation between changes in CSF dopamine turnover and development of dyskinesia in Parkinson's disease

(2008) Gianluigi Lunardi et al.   PARKINSONISM & RELATED DISORDERS